Cubist Pharmaceuticals, Inc. 3Q10 Total Net Revenues Up 13% to $162.1 Million

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced results for the third quarter ended September 30, 2010.
MORE ON THIS TOPIC